Sangamo Therapeutics Stock Slumps After Pfizer Terminates Hemophilia A Gene Therapy Partnership

Sangamo Therapeutics Stock Slumps After Pfizer Terminates Hemophilia A Gene Therapy Partnership

Sangamo Therapeutics’ (SGMO) shares were sinking intraday Tuesday after the company said its partner

Leave a Reply

Your email address will not be published. Required fields are marked *

THIS CONTENT IS CURRENTLY LOCKED.

ApexDator is scheduled to launch in 2026.

Contact the organization’s assistant to receive early access and related benefits in advance, including AI-powered stock picks, signals, and expert-backed research as features roll out.